UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058358
Receipt number R000066715
Scientific Title Investigation of the Longitudinal Effects of Shichimotsukokato on Renal Function in Patients with Chronic Kidney Disease
Date of disclosure of the study information 2025/07/03
Last modified on 2025/07/03 14:38:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of the Longitudinal Effects of Shichimotsukokato on Renal Function in Patients with Chronic Kidney Disease

Acronym

Investigation of the Longitudinal Effects of Shichimotsukokato on Renal Function in Patients with Chronic Kidney Disease

Scientific Title

Investigation of the Longitudinal Effects of Shichimotsukokato on Renal Function in Patients with Chronic Kidney Disease

Scientific Title:Acronym

Investigation of the Longitudinal Effects of Shichimotsukokato on Renal Function in Patients with Chronic Kidney Disease

Region

Japan


Condition

Condition

Chronic Kidney Disease (CKD)

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the longitudinal effects of Shichimotsukokato on renal function in patients with CKD

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

eGFR slope before and after one year of Shichimotsukokato administration

Key secondary outcomes

Change in SBP, DBP, and urinary protein before and after one year treatment
Adverse events


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Age=>18 years
2. History of medical visits to the participating institutions between April 2019 and May 2025
3. Diagnosed with CKD according to the Japanese Guideline for CKD 2023
4. Continuously administered Shichimotsukokato for at least one year
5. Availability of blood test data, including eGFR at three time points (one year before initiation, at initiation, and one year after initiation of Shichimotsukokato)

Key exclusion criteria

Individuals who refuse to participate in this study

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Kazushi
Middle name
Last name Uneda

Organization

Aizu Medical Center, Fukushima Medical University

Division name

Department of Kampo Medicine

Zip code

969-3492

Address

21-2 Maeda, Tanisawa, Kawahigashi, Aizuwakamatsu, Fukushima

TEL

+81-242-75-2100

Email

uneda@fmu.ac.jp


Public contact

Name of contact person

1st name Kazushi
Middle name
Last name Uneda

Organization

Aizu Medical Center, Fukushima Medical University

Division name

Department of Kampo Medicine

Zip code

969-3492

Address

21-2 Maeda, Tanisawa, Kawahigashi, Aizuwakamatsu, Fukushima

TEL

+81-242-75-2100

Homepage URL

https://www.fmu.ac.jp/amc/index.html

Email

uneda@fmu.ac.jp


Sponsor or person

Institute

Fukushima Medical University

Institute

Department

Personal name

Kazushi Uneda


Funding Source

Organization

None.

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Tenjinbashi Clinic

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Department of Kampo Medicine, Aizu Medical Center, Fukushima Medical University

Address

21-2 Maeda, Tanisawa, Kawahigashi, Aizuwakamatsu, Fukushima 969-3492, Japan

Tel

0242-75-2100

Email

uneda@fmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 07 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2025 Year 05 Month 21 Day

Date of IRB

2025 Year 05 Month 21 Day

Anticipated trial start date

2025 Year 06 Month 01 Day

Last follow-up date

2025 Year 07 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Analysis period: June 2025 to March 2026


Management information

Registered date

2025 Year 07 Month 03 Day

Last modified on

2025 Year 07 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066715